Sanofi
SNY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001121404
No open-market purchases or sales by Sanofi insiders were filed in the last 90 days; 718 institutions reported holding it in 13F filings for Q2 2026, worth $8.08B in total; Maverick Capital is the only superinvestor holding it.
Other share classesSNYNF
Holders of 5% or more of SNY
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Sanofi, largest stake first. The change is against the holder's previous filing.
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
20 Schedule 13D and 13G filings on Sanofi, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jul 22, 20269:50 AM ET | Amundiand 1 other | 13G/A | 5.65%68.7M shares | +0.61 ppfrom 5.04% | Jun 30, 2026 | SEC |
| Apr 10, 20269:58 AM ET | Amundiand 1 other | 13G/A | 5.04%61.5M shares | −0.07 ppfrom 5.11% | Mar 31, 2026 | SEC |
| Feb 17, 20264:57 PM ET | Amundiand 1 other | 13G/A | 5.11%62.7M shares | −0.10 ppfrom 5.21% | Dec 31, 2025 | SEC |
| Nov 14, 20255:34 PM ET | Amundiand 1 other | 13G/A | 5.21%63.9M shares | +0.18 ppfrom 5.03% | Sep 30, 2025 | SEC |
| Aug 13, 20254:40 PM ET | Amundiand 1 other | 13G/A | 5.03%61.8M shares | +0.23 ppfrom 4.80% | Jun 30, 2025 | SEC |
| May 12, 20254:50 PM ET | Amundiand 1 other | 13G/A | 4.80%59.3M shares | −0.30 ppfrom 5.10%Below 5% | Mar 31, 2025 | SEC |
| Feb 14, 202512:14 PM ET | Amundiand 1 other | 13G/A | 5.10%64.3M shares | – | Dec 31, 2024 | SEC |
| Nov 7, 2024 | Amundi | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Amundi | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Dodge & Cox | 13G/AOld format | – | – | – | SEC |
| Feb 6, 20243:14 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Dodge & Cox | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | Amundi | 13G/AOld format | – | – | – | SEC |
| Feb 7, 20232:10 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 22, 2022 | Amundi | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Dodge & Cox | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | Amundi | 13G/AOld format | – | – | – | SEC |
| Feb 3, 20224:29 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Amundi | 13GOld format | – | New | – | SEC |
| Feb 1, 20218:17 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Sanofi shares.
No Form 144 notices for Sanofi are on file.